Jazz Pharmaceuticals plc Overview
Jazz Pharmaceuticals plc Target Price
Analysts' average 12-month price target for Jazz Pharmaceuticals plc is $270.
Get informed when a big investor buys or sells
+ FollowShare Price
$248.95
Average Target Price
$272.04
9.3% upside
9.3% upside26 analysts in the last 4 months
High: $315 | Low: $225
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-08-04 | Deutsche Bank | $287 | 15.3% upside |  |
| 2026-08-04 | Truist Financial | $300 | 20.5% upside | |
| 2026-08-04 | Morgan Stanley | $280 | 12.5% upside | |
| 2026-08-04 | Truist Financial | $264 | 6% upside | |
| 2026-08-04 | NeedhamAmi Fadia | $292 | 17.3% upside | |
| 2026-08-04 | UBS | $315 | 26.5% upside | |
| 2026-08-04 | Wells Fargo | $300 | 20.5% upside | |
| 2026-08-04 | Stifel Nicolaus | $275 | 10.5% upside | |
| 2026-08-04 | Piper Sandler | $310 | 24.5% upside | |
| 2026-08-04 | Robert W. Baird | $280 | 12.5% upside | |
| 2026-08-04 | Barclays | $270 | 8.5% upside | |
| 2026-07-16 | Canaccord GenuityGary Nachman | $290 | 16.5% upside | |
| 2026-07-14 | Wells Fargo | $285 | 14.5% upside | |
| 2026-07-14 | Barclays | $260 | 4.4% upside | |
| 2026-07-09 | Deutsche Bank | $270 | 8.5% upside | |
| 2026-07-07 | Truist FinancialGregory Renza | $254 | 2% upside | |
| 2026-06-09 | Truist FinancialGregory Renza | $256 | 2.8% upside | |
| 2026-05-27 | Barclays | $253 | 1.6% upside | |
| 2026-05-22 | Piper Sandler | $301 | 20.9% upside | |
| 2026-05-21 | Bernstein | $229 |  8% downside | |
| 2026-05-19 | UBSAshwani Verma | $307 | 23.3% upside | |
| 2026-05-07 | Morgan StanleySean Laaman | $245 | 1.6% downside | |
| 2026-05-06 | Raymond JamesTiago Fauth | $239 | 4% downside | |
| 2026-05-06 | Robert W. Baird | $252 | 1.2% upside | |
| 2026-05-06 | BarclaysEtzer Darout | $234 | 6% downside | |
| 2026-04-20 | BarclaysEtzer Darout | $225 | 9.6% downside | |
| 2026-04-10 | Raymond James | $227 | 8.8% downside | |
| 2026-03-09 | BarclaysEtzer Darout | $224 | 10% downside | |
| 2026-01-12 | NeedhamAmi Fadia | $235 | 5.6% downside | |
| 2026-01-08 | Morgan StanleySean Laaman | $225 | 9.6% downside | |
| 2025-12-10 | Piper SandlerDavid Amsellem | $219 | 12% downside | |
| 2025-11-24 | UBSAshwani Verma | $188 | 24.5% downside | |
| 2025-11-17 | RBC Capital | $194 | 22.1% downside | |
| 2025-11-17 | Morgan StanleySean Laaman | $205 | 17.7% downside | |
| 2025-10-24 | Morgan Stanley | $183 | 26.5% downside | |
| 2025-10-22 | Wells Fargo | $170 | 31.7% downside | |
| 2025-10-20 | Morgan Stanley | $180 | 27.7% downside | |
| 2025-08-28 | Truist FinancialJoon Lee | $205 | 17.7% downside | |
| 2025-08-28 | RBC CapitalGregory Renza | $151 | 39.3% downside | |
| 2025-08-28 | Morgan Stanley | $163 | 34.5% downside | |
| 2025-07-15 | Deutsche BankDavid Hoang | $152 | 38.9% downside | |
| 2025-03-06 | Truist Financial | $230 | 7.6% downside | |
| 2025-02-27 | BarclaysBalaji Prasad | $200 | 19.7% downside | |
| 2024-11-21 | JefferiesAkash Tewar | $160 | 35.7% downside | |
| 2024-11-18 | Robert W. BairdJoel Beatty | $162 | 34.9% downside | |
| 2024-10-23 | RBC CapitalDaniel Busb | $179 | 28.1% downside | |
| 2024-09-11 | Stifel NicolausAnnabel Samimy | $230 | 7.6% downside | |
| 2024-06-05 | Goldman SachsAndrea Tan | $169 | 32.1% downside | |
| 2024-05-02 | RBC CapitalDaniel Busb | $176 | 29.3% downside | |
| 2024-03-20 | Piper SandlerDavid Amsellem | $188 | 24.5% downside | |